Answer
The mean half-life of loncastuximab tesirine at steady state is 20.5 days, with a standard deviation of 5.72 days.
Sources for this answer
- Zynlonta, 10mg, powder for concentrate for solution for infusionSwedish Orphan Biovitrum Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 8Document updated
Sources checked